Published in Medical Device Law Weekly, February 27th, 2005
The program presents a new way of doing business with Agilent that allows scientists to share their custom microarray designs either with designated groups while maintaining control of their intellectual property, or with the scientific community at large. Agilent prints the microarrays and makes them available on demand, ensuring quality production and distribution.
The program is expected to particularly benefit scientists in consortia working collaboratively on the study of specific organisms. The first two organisms to be made available through this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.